Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, announces the Company’s stock is included in the Hang Seng China Enterprises Index according to the Hang Seng Indexes Company’s latest results of review.
November 21, 2021
· 5 min read